Answer
Jul 09, 2025 - 02:58 PM
Onglyza (saxagliptin) is a medication used to help manage blood sugar levels in adults with type 2 diabetes. Clinical studies have shown that Onglyza can lower hemoglobin A1C levels by approximately 0.5% to 0.9% when added to diet and exercise, and sometimes in combination with other diabetes medications. The exact reduction can vary depending on individual factors such as baseline A1C levels and the presence of other medications.
